Research sites are critically important to the development and testing of new therapies. They help bring new treatments to patients—and provide the reliable data that stops the development of unsuccessful projects. While active, organized sites are essential to support the conduct of clinical trials, many clinicians who explore participating in clinical research never proceed beyond a first trial. This paper discusses what high-performing research sites have in common, and what makes sponsors return to them again and again.
Error - something went wrong!
Other content in this Stream
Subject Recruitment Materials: Understanding the Requirements for IRB Review
Recruiting Patients & Time Management: Top Tips for Dealing with the Most Critical Resource in Research
Clinical Trial Recruitment Practices: The Evolution of Ethical Considerations
Clinical Trials and Social Media - Friends or Foes
Rare Disease Case Study: Pediatric Sickle Cell Anemia
Our client, a Top 10 pharmaceutical company, needed to boost enrollment for their phase ll pediatric sickle cell anemia study.
Rare Disease Case Study: Familial Amyloidosis
Our client, a top-tier CRO, was faced with the challenge of enrolling for a non-interventional screening study in the familial amyloidotic cardiomyopathy (FAC) patient population.
Rare & Orphan Disease Endpoints: Challenges & Examples from Neurodevelopment
Personalized Medicine Requires Personalized Measurement
Patient Engagement Services Overview
Patient Recruitment for Ophthalmology Study (Glaucoma and Retinal Disease)
A leading pharma company needed assistance to rescue their enrolling ophthalmology study. The sponsor was attempting to complete enrollment for a normative, glaucoma and retinal disease study.
Patient Recruitment for Multi-Protocol Global Program (Phase III Cardiovascular Disease)
Our customer needed support for a global, multi-protocol program which was behind with enrollment.
Looking Ahead to 2018: Insights into Clinical Research Trends from Our Experts
In this paper, WCG thought-leaders provide insights on what they anticipate in 2018 in clinical trial technology, regulatory changes, and scientific developments.
Placebo Response in Clinical Trials: Approaches to Mitigation
Case Study: Engaging Research Naive Sites
Case Study: Customized Scale Development
Case Study: In-Study Quality Control
Case Study: Addressing Placebo Response
Case Study: Suicidality Assessment in China
Case Study: Training Program for Japan